Home › Cyclica And Dalton Announce Collaboration Agreement To Identify And Develop New Drug Candidates
 

Keywords :   


Cyclica And Dalton Announce Collaboration Agreement To Identify And Develop New Drug Candidates

2013-04-12 09:19:56| drugdiscoveryonline News Articles

Jason Mitakidis, President and CEO of Cyclica, Peter Pekos, President and CEO of Dalton Pharma Services and Dr. Judd Berman, Co-Founder of Dalton Medicinal Chemistry today announced a collaboration for the joint identification and development of a number of new drug candidates

Tags: agreement develop drug identify

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
08.07Eastern North Pacific Tropical Weather Outlook
08.07Atlantic Tropical Weather Outlook
08.07Tropical Storm Beryl Potential Storm Surge Flooding Map
07.07Tropical Storm Beryl Probabilistic Storm Surge Graphics
07.07Tropical Storm Beryl Graphics
07.07Tropical Storm Beryl Forecast Discussion Number 37
07.07Tropical Storm Beryl Storm Surge Watch/Warning Map
07.07Tropical Storm Beryl Wind Speed Probabilities Number 37
More »